A biobank of colorectal cancer patient-derived xenografts
Journal Title
Cancers (Basel)
Publication Type
Journal Article
Colorectal cancer (CRC) is a challenging disease, with a high mortality rate and limited effective treatment options, particularly for late-stage disease. Patient-derived xenografts (PDXs) have emerged as an informative, renewable experimental resource to model CRC architecture and biology. Here, we describe the generation of a biobank of CRC PDXs from stage I to stage IV patients. We demonstrate that PDXs within our biobank recapitulate the histopathological and mutation features of the original patient tumor. In addition, we demonstrate the utility of this resource in pre-clinical chemotherapy and targeted treatment studies, highlighting the translational potential of PDX models in the identification of new therapies that will improve the overall survival of CRC patients.
WEHI Research Division(s)
Personalised Oncology
PubMed ID
Open Access at Publisher's Site
Rights Notice
Refer to copyright notice on published article.

Creation Date: 2020-10-17 02:40:34
Last Modified: 2020-11-03 09:53:45
An error has occurred. This application may no longer respond until reloaded. Reload 🗙